Cargando…

Effect of Resveratrol on Serum Levels of Type II Collagen and Aggrecan in Patients with Knee Osteoarthritis: A Pilot Clinical Study

Treatment of knee osteoarthritis (OA) remains a challenging concern. Preclinical studies provided accumulating evidence on resveratrol efficacy in ameliorating degenerative articular damage. The present study was conducted to evaluate the effects of resveratrol as monotherapy on the serum level of t...

Descripción completa

Detalles Bibliográficos
Autor principal:	Marouf, Bushra Hassan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601845/ https://www.ncbi.nlm.nih.gov/pubmed/34805399 http://dx.doi.org/10.1155/2021/3668568

Ejemplares similares

Efficacy and safety of co-administration of resveratrol with meloxicam in patients with knee osteoarthritis: a pilot interventional study
por: Hussain, Saad Abdulrahman, et al.
Publicado: (2018)

Blood and urine biomarkers in osteoarthritis – an update on cartilage associated type II collagen and aggrecan markers
por: Bay-Jensen, Anne C., et al.
Publicado: (2022)

Correlation between serum pro inflammatory cytokines and clinical scores of knee osteoarthritic patients using resveratrol as a supplementary therapy with meloxicam
por: Marouf, Bushra Hassan, et al.
Publicado: (2021)

Desumoylation of aggrecan and collagen II facilitates degradation via aggrecanases in IL-1β-mediated osteoarthritis
por: Zhu, Bing, et al.
Publicado: (2019)

Association between synovial fluid levels of aggrecan ARGS fragments and radiographic progression in knee osteoarthritis
por: Larsson, Staffan, et al.
Publicado: (2010)

Biological variation of human aggrecan ARGS neoepitope in synovial fluid and serum in early-stage knee osteoarthritis and after knee injury
por: Larsson, Staffan, et al.
Publicado: (2022)

UNDENATURED COLLAGEN TYPE II FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
por: SADIGURSKY, DAVID, et al.
Publicado: (2022)

Aggrecan heterogeneity in articular cartilage from patients with osteoarthritis
por: Mort, John S., et al.
Publicado: (2016)

Activation of GPR40 Suppresses AGE-Induced Reduction of Type II Collagen and Aggrecan in Human SW1353 Chondrocytes
por: Gu, Jiaxiang, et al.
Publicado: (2020)

Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial
por: Crowley, David C., et al.
Publicado: (2009)

An Anterior Cruciate Ligament Rupture Increases Levels of Urine N-terminal Cross-linked Telopeptide of Type I Collagen, Urine C-terminal Cross-linked Telopeptide of Type II Collagen, Serum Aggrecan ARGS Neoepitope, and Serum Tumor Necrosis Factor–α
por: Hagemans, Frans J.A., et al.
Publicado: (2021)

Bone morphogenic protein (BMP-2) enhances expression of type II collagen and aggrecan in human chondrocytes in 3D alginate cultures
por: Aicher, WK, et al.
Publicado: (2004)

The study of targeted blocking SDF-1/CXCR4 signaling pathway with three antagonists on MMPs, type II collagen, and aggrecan levels in articular cartilage of guinea pigs
por: Wang, Guoliang, et al.
Publicado: (2020)

Serum Leptin and Resistin Levels in Knee Osteoarthritis—Clinical and Radiologic Links: Towards Precise Definition of Metabolic Type Knee Osteoarthritis
por: Lambova, Sevdalina Nikolova, et al.
Publicado: (2021)

Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study
por: Larsson, Staffan, et al.
Publicado: (2009)

Aggrecan Hypomorphism Compromises Articular Cartilage Biomechanical Properties and Is Associated with Increased Incidence of Spontaneous Osteoarthritis
por: Alberton, Paolo, et al.
Publicado: (2019)

Serum Collagen Type II Cleavage Epitope and Serum Hyaluronic Acid as Biomarkers for Treatment Monitoring of Dogs with Hip Osteoarthritis
por: Vilar, José M., et al.
Publicado: (2016)

The role of aggrecan in normal and osteoarthritic cartilage
por: Roughley, Peter J, et al.
Publicado: (2014)

Prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type II collagen biomarkers in a retrospective observational study
por: Sobue, Yasumori, et al.
Publicado: (2017)

Activation of β-catenin signaling in aggrecan-expressing cells in temporomandibular joint causes osteoarthritis-like defects
por: Hui, Tianqian, et al.
Publicado: (2018)

Correlation Analysis of C‐terminal telopeptide of collagen type II and Interleukin‐1β for Early Diagnosis of Knee Osteoarthritis
por: Liu, Cai‐xia, et al.
Publicado: (2019)

Matrilin-3 Induction of IL-1 receptor antagonist Is required for up-regulating collagen II and aggrecan and down-regulating ADAMTS-5 gene expression
por: Jayasuriya, Chathuraka T, et al.
Publicado: (2012)

The C-Type Lectin of the Aggrecan G3 Domain Activates Complement
por: Melin Fürst, Camilla, et al.
Publicado: (2013)

Aggrecan: a new biomarker for acute type A aortic dissection
por: König, Karl C., et al.
Publicado: (2021)

A systematic review of the relationship between the distributions of aggrecan gene VNTR polymorphism and degenerative disc disease/osteoarthritis
por: Cong, L., et al.
Publicado: (2018)

Matrix-Bound Growth Factors are Released upon Cartilage Compression by an Aggrecan-Dependent Sodium Flux that is Lost in Osteoarthritis
por: Keppie, Stuart J, et al.
Publicado: (2021)

Serum Levels of Proinflammatory Cytokines in Painful Knee Osteoarthritis and Sensitization
por: Imamura, Marta, et al.
Publicado: (2015)

Effect of Age-Related Cartilage Turnover on Serum C-Telopeptide of Collagen Type II and Osteocalcin Levels in Growing Rabbits with and without Surgically Induced Osteoarthritis
por: Huang, Chung-Cheng, et al.
Publicado: (2014)

Biomarkers, type II collagen, glucosamine and chondroitin sulfate in osteoarthritis follow-up: the “Magenta osteoarthritis study”
por: Scarpellini, M., et al.
Publicado: (2008)

Efficacy and safety of native type II collagen in modulating knee osteoarthritis symptoms: a randomised, double-blind, placebo-controlled trial
por: Luo, Cheng, et al.
Publicado: (2022)

The JAK/STAT pathway but not the Erk1/2 pathway mediates IL-6/sIL-6R downregulation of type II collagen, aggrecan core and link protein transcription in articular chondrocytes
por: Bogdanowicz, P, et al.
Publicado: (2003)

Laboratory Indicators of Aggrecan Turnover in Juvenile Idiopathic Arthritis
por: Winsz-Szczotka, Katarzyna, et al.
Publicado: (2016)

Juvenile Hippocampal CA2 Region Expresses Aggrecan
por: Noguchi, Asako, et al.
Publicado: (2017)

Development of a highly sensitive chemiluminescence immunoassay for quantification of aggrecanase-generated ARGS aggrecan fragments in serum
por: He, Yi, et al.
Publicado: (2021)

Protective Effect of Resveratrol on Knee Osteoarthritis and its Molecular Mechanisms: A Recent Review in Preclinical and Clinical Trials
por: Yang, Shenglei, et al.
Publicado: (2022)

Type X collagen levels are elevated in serum from human osteoarthritis patients and associated with biomarkers of cartilage degradation and inflammation
por: He, Yi, et al.
Publicado: (2014)

CHANGES IN LEVELS OF CARTILAGE OLIGOMERIC PROTEINASE AND URINARY C-TERMINAL TELOPEPTIDE OF TYPE II COLLAGEN IN SUBJECTS WITH KNEE OSTEOARTHRITIS AFTER DEXTROSE PROLOTHERAPY: A RANDOMIZED CONTROLLED TRIAL
por: WALUYO, Yose, et al.
Publicado: (2021)

Effect of Silibinin on Dyslipidemia and Glycemic Alteration Associated with Polycystic Ovarian Syndrome: An Experimental Study on Rats
por: Marouf, Bushra Hassan
Publicado: (2022)

Clinical and Radiological Study of Serum Fluoride in Relation to Knee Osteoarthritis
por: Singh, VK, et al.
Publicado: (2020)

Intra-Articular Injection of Hydrolyzed Collagen to Treat Symptoms of Knee Osteoarthritis. A Functional In Vitro Investigation and a Pilot Retrospective Clinical Study
por: De Luca, Paola, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8619j3vhvv935261bcjf1sh732